@article{5f3c87770a6a4b008349dbb45ebe24e3,
title = "Genetic Testing for Early-Onset Atrial Fibrillation-Is It Time to Personalize Care?",
author = "McNally, {Elizabeth M.} and Khan, {Sadiya S.}",
note = "Funding Information: reported receiving grants from the National Institutes of Health and the American Heart Association to Northwestern University; consulting fees from Amgen, AstraZeneca, Avidity, Cytokinetics, Janssen, Pfizer, PepGen, Stealth Biotherapeutics, Tenaya Therapeutics, and Invitae Corp outside the submitted work; and being the founder of Ikaika Therapeutics. Dr Khan reported receiving grants from the American Heart Association and the National Institutes of Health outside the submitted work. No other disclosures were reported.",
year = "2022",
month = jul,
doi = "10.1001/jamacardio.2022.0909",
language = "English (US)",
volume = "7",
pages = "669--671",
journal = "JAMA cardiology",
issn = "2380-6583",
publisher = "American Medical Association",
number = "7",
}